Newly diagnosed advanced International Federation of Gynecology and Obstetrics (FIGO) stage III A or greater epithelial ovarian cancer addressed to neoadjuvant chemotherapy (NACT) and interval debulking surgery (IDS);
Availability of freshly frozen tissue and FFPE tissue from both exploratory laparoscopy (baseline) and IDS;
Age between 18 and 80 years;
Estimated life expectancy of at least 4 weeks;
Signed informed consent
You may not be if
Non-serous histology at frozen section;
Patients with a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (\> 10 mg equivalent prednisone/daily) or any other form of immunosuppressive therapy within 7 days prior to the enrollment;
Previous diagnosis of cancer within 5 years.
Clareo Health | Proteogenomic Signatures Analysis In Ovarian Cancer
